Clinical Trials Directory

Trials / Completed

CompletedNCT02765945

Exercise as an Modulator of Immunological Risk Factors for Osteoporosis

The Effect of Long-term Exercise on the Production of Osteoclastogenic and Anti-osteoclastogenic Cytokines by Peripheral Blood Mononuclear Cells and on Serum Markers of Bone Metabolism

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
43 (actual)
Sponsor
East Tennessee State University · Academic / Other
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Accepted

Summary

This is the second phase of a study designed to determine the immunological effects of long-term exercise on risk factors for ischemic heart disease (phase 1) and osteoporosis (phase 2). The results indicate that six months of moderate intensity exercise reduces bone resorption and increases the secretion of anti-osteoclastogenic cytokines by peripheral blood mononuclear cells.

Detailed description

In a before and after trial involving 43 healthy adults the investigators measured the effect of six months of supervised exercise on the spontaneous and phytohemagglutinin-induced production of osteoclastogenic cytokines (interleukin-1α, tumor necrosis factor-α), anti-osteoclastogenic cytokines (transforming growth factor-β, interleukins 4 and10), pleiotropic cytokines with variable effects on osteoclastogenesis (interferon-γ, interleukin-6), and T cell growth and differentiation factors (interleukins 2 and 12) by peripheral blood mononuclear cells. The investigators also measured lymphocyte phenotypes, and serum markers of bone formation (osteocalcin), bone resorption (C-terminal telopeptides of Type I collagen), and bone homeostasis (estradiol, vitamin D2, testosterone, parathyroid hormone, insulin-like growth factor).

Conditions

Interventions

TypeNameDescription
OTHERSupervised exercise programSubjects were enrolled in a hospital-based wellness center where, after analysis of their medical history and previous levels of physical activity ands documentation of a normal exercise stress test, they chose individually tailored exercise programs

Timeline

Start date
1996-12-01
Primary completion
1998-04-01
Completion
1998-04-01
First posted
2016-05-09
Last updated
2016-05-09

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02765945. Inclusion in this directory is not an endorsement.